Ryan Specialty Holdings, Inc. (NYSE:RYAN) Receives $73.50 Consensus Target Price from Analysts

Ryan Specialty Holdings, Inc. (NYSE:RYAN - Get Free Report) has been assigned an average rating of "Hold" from the twelve analysts that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $73.50.

A number of research analysts recently issued reports on RYAN shares. Bank of America raised their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a research note on Thursday, October 10th. The Goldman Sachs Group increased their target price on Ryan Specialty from $64.00 to $72.00 and gave the company a "neutral" rating in a research note on Wednesday, October 9th. BMO Capital Markets raised Ryan Specialty from a "market perform" rating to an "outperform" rating and lifted their price target for the stock from $65.00 to $75.00 in a research report on Tuesday, September 24th. Morgan Stanley assumed coverage on Ryan Specialty in a research report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price objective for the company. Finally, Wells Fargo & Company increased their price target on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an "equal weight" rating in a report on Thursday, October 10th.

Insiders Place Their Bets

In other news, Director David P. Bolger sold 7,055 shares of the stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total transaction of $500,058.40. Following the completion of the sale, the director now owns 78,149 shares of the company's stock, valued at $5,539,201.12. This represents a 8.28 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the business's stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $65.17, for a total transaction of $2,280,950.00. Following the completion of the sale, the director now directly owns 50,400 shares in the company, valued at $3,284,568. This represents a 40.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 126,936 shares of company stock worth $8,536,282. Company insiders own 11.10% of the company's stock.

Institutional Investors Weigh In On Ryan Specialty

Several institutional investors have recently bought and sold shares of RYAN. Hollencrest Capital Management bought a new stake in Ryan Specialty during the 3rd quarter worth about $25,000. Assetmark Inc. bought a new stake in Ryan Specialty during the third quarter worth about $34,000. Crewe Advisors LLC acquired a new position in Ryan Specialty during the second quarter valued at approximately $39,000. Quarry LP grew its stake in Ryan Specialty by 109.3% in the third quarter. Quarry LP now owns 808 shares of the company's stock valued at $54,000 after purchasing an additional 422 shares in the last quarter. Finally, GAMMA Investing LLC increased its position in shares of Ryan Specialty by 106.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,249 shares of the company's stock worth $83,000 after purchasing an additional 644 shares during the last quarter. Institutional investors own 84.82% of the company's stock.

Ryan Specialty Stock Up 0.9 %

Ryan Specialty stock traded up $0.60 during trading hours on Tuesday, hitting $64.49. The company had a trading volume of 321,857 shares, compared to its average volume of 875,258. The firm's fifty day moving average is $70.05 and its 200-day moving average is $64.93. The firm has a market capitalization of $16.89 billion, a P/E ratio of 83.75, a price-to-earnings-growth ratio of 1.52 and a beta of 0.67. Ryan Specialty has a fifty-two week low of $41.65 and a fifty-two week high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting analysts' consensus estimates of $0.41. The company had revenue of $604.69 million during the quarter, compared to the consensus estimate of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business's quarterly revenue was up 20.5% on a year-over-year basis. During the same period last year, the business earned $0.32 EPS. On average, research analysts forecast that Ryan Specialty will post 1.82 earnings per share for the current year.

Ryan Specialty Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were paid a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty's payout ratio is 57.14%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.